AGEN(Agenus Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $295.67M | $98.02M | $156.31M | $103.46M | $114.20M |
| 毛利润 | $292.19M | $87.46M | $153.20M | $102.98M | $113.17M |
| 营业利润 | $25.75M | −$179.43M | −$159.55M | −$120.47M | −$20.17M |
| 净利润 | −$28.72M | −$230.66M | −$257.44M | −$232.27M | −$3.08M |
| 经营现金流 | $10.14M | −$175.37M | −$224.20M | −$158.31M | −$77.19M |
| 自由现金流 | −$23.67M | −$228.44M | −$234.16M | −$158.89M | −$77.20M |
| 摊薄每股收益 | $-2.20 | $-15.64 | $-13.75 | $-10.59 | $0.00 |